2. Academic Validation
  3. PRMT6-mediated ADMA promotes p62 phase separation to form a negative feedback loop in ferroptosis

PRMT6-mediated ADMA promotes p62 phase separation to form a negative feedback loop in ferroptosis

  • Theranostics. 2024 Jul 2;14(10):4090-4106. doi: 10.7150/thno.94789.
Lifeng Feng 1,  Lini Chen 1,  Weikai Wang 1,  Qi Wei 1,  Minqiang Chen 2,  Xin Jiang 1,  Shiman Hu 1,  Yuchen Wu 1,  Lian Duan 3,  Liyuan Zhu 1,  Xian Wang 1,  Hongchuan Jin 1
Affiliations

Affiliations

  • 1 Department of Medical Oncology, Zhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases, Cancer Center of Zhejiang University, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • 2 Department of Hepatobiliary and Pancreatic Surgery, Jinhua Municipal Central Hospital, Jinhua, Zhejiang, China.
  • 3 Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
PMID: 38994016 DOI: 10.7150/thno.94789
Abstract

Purpose: Due to intrinsic defensive response, ferroptosis-activating targeted therapy fails to achieve satisfactory clinical benefits. Though p62-Keap1-Nrf2 axis is activated to form a negative feedback loop during Ferroptosis induction, how p62 is activated remains largely unknown. Methods: MTS assay was applied to measure cell growth. Lipid ROS was detected with C11-BODIPY reagent by flow cytometer. Quantitative Real-Time PCR (qPCR) and western blotting were performed to determine mRNA and protein level. Immunofluorescence (IF) was performed to examine the distribution of proteins. Fluorescence recovery after photobleaching (FRAP) was adopted to evaluate p62 phase separation. Immunoprecipitation (IP), co-IP and Proximal ligation assay (PLA) were performed to detected protein posttranslational modifications and protein-protein interactions. Tumor xenograft model was employed to inspect in vivo growth of pancreatic Cancer cells. Results: Upon Ferroptosis induction, Nuclear Factor E2 Related Factor 2 (Nrf2) protein and its downstream genes such as HMOX1 and NQO1 were upregulated. Knockdown of p62 significantly reversed Nrf2 upregulation and Keap1 decrease after Ferroptosis induction. Knockdown of either p62 or Nrf2 remarkably sensitized Ferroptosis induction. Due to augmented p62 phase separation, formation of p62 bodies were increased to recruit Keap1 after Ferroptosis induction. Protein arginine methyltransferase 6 (PRMT6) mediated asymmetric dimethylarginine (ADMA) of p62 to increase its oligomerization, promoting p62 phase separation and p62 body formation. Knockdown of p62 or PRMT6 notably sensitized pancreatic Cancer cells to Ferroptosis both in vitro and in vivo through suppressing Nrf2 signaling. Conclusion: During Ferroptosis induction, PRMT6 mediated p62 ADMA to promote its phase separation, sequestering Keap1 to activate Nrf2 signaling and inhibit Ferroptosis. Therefore, targeting PRMT6-mediated p62 ADMA could be a new option to sensitize Ferroptosis for Cancer treatment.

Keywords

ADMA; PRMT6; ferroptosis; p62; phase separation.

Figures
Products